{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By OLAF STORBECK and KEVIN ALLISON", "person": [{"rank": 1, "role": "reported", "firstname": "Olaf", "organization": "", "lastname": "STORBECK"}, {"rank": 2, "role": "reported", "firstname": "Kevin", "organization": "", "lastname": "ALLISON"}]}, "abstract": null, "type_of_material": "News", "word_count": "392", "lead_paragraph": "Amid reports of an offer, analysts look at the numbers to determine how a deal would work.", "pub_date": "2016-05-13T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "A Bayer-Monsanto Tie-Up Could Be a Bitter Pill", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "Amid reports of an offer, analysts look at the numbers to determine how a deal would work.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/05/13/business/dealbook/a-bayer-monsanto-tie-up-could-be-a-bitter-pill.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Monsanto Company", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Bayer AG", "name": "organizations"}], "blog": [], "_id": "5734d07b38f0d878c2872d7a", "source": "The New York Times"}